These are related to the medication mechanism itself, not the delivery route
Market Projections and Access Considerations Analyst projections suggest the GLP-1 market could reach $150 billion by 2030, driven by expanding indications and growing patient populations ^42
The acquired data set composed of the peak intensities was generated for a targeted mass inclusion list of metabolites with Fiehnlab BinBase database annotations 37 , database identifier [i.e., InChI key 40 , the compound annotation metadata (i.e., retention index, quantification mass, BinBase identifier, and mass spectrum), and PubChem and KEGG annotations 41,42
GLP-1 and GLP-1RA can regulate glucose levels, by stimulating insulin secretion and reducing the release of glucagon
The early results for retatrutide have gotten a lot of industry attention